TRAW Advances Broad-Spectrum Antiviral Agent Against Hantavirus, Ebola, Lassa Fever with Novel Dual-Strike Mechanism
Traws Pharma, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.47
-9.0% in 1d after detection
Post-detection moves
1h
-4.2%
1d
-9.0%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS